segesterone-ethinyl estradiol vaginal ring Annovera
Selected indexed studies
- Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. (Am Fam Physician, 2020) [PMID:32412221]
- Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. (Obstet Gynecol, 2021) [PMID:34011888]
- A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year. (Expert Opin Drug Deliv, 2020) [PMID:32410464]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hormonal contraception in women with endometriosis: a systematic review. (2019) pubmed
- Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. (2020) pubmed
- Vaginal ring contraception. (2011) pubmed
- A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year. (2020) pubmed
- Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation. (2019) pubmed
- Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users. (2023) pubmed
- Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. (2021) pubmed
- Contraceptive vaginal ring containing segesterone acetate and ethinyl estradiol: long-acting, patient-controlled, procedure-free, reversible prescription birth control. (2019) pubmed
- Etonogestrel. (2006) pubmed
- A New Year-Long Combination Hormonal Contraceptive. (2019) pubmed